{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T16:00:25Z","timestamp":1784304025103,"version":"3.55.0"},"reference-count":201,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100009287","name":"NSW Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009287","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/j.clinthera.2020.08.008","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T09:03:59Z","timestamp":1600074239000},"page":"1857-1879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy"],"prefix":"10.1016","volume":"42","author":[{"given":"Dinesh","family":"Selvakumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe E.","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James J.H.","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2020.08.008_bib1","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/nature11682","article-title":"Mammalian heart renewal by pre-existing cardiomyocytes","volume":"493","author":"Senyo","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib2","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.cell.2015.05.026","article-title":"Dynamics of cell generation and turnover in the human heart","volume":"161","author":"Bergmann","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib3","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/j.hlc.2016.11.002","article-title":"New developments in cardiac regeneration","volume":"26","author":"Le","year":"2017","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.clinthera.2020.08.008_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1161\/CIRCRESAHA.116.303577","article-title":"The biological basis for cardiac repair after myocardial infarction","volume":"119","author":"Prabhu","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib5","doi-asserted-by":"crossref","first-page":"7","DOI":"10.15420\/cfr.2016:25:2","article-title":"Global public health burden of heart failure","volume":"3","author":"Savarese","year":"2017","journal-title":"Card Fail Rev"},{"key":"10.1016\/j.clinthera.2020.08.008_bib6","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib7","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1126\/science.362.6414.513","article-title":"Suspect science leads to pause in stem cell trial","volume":"362","author":"Kaiser","year":"2018","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2020.08.008_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1126\/science.aaz3650","article-title":"Stem cells and the heart\u2014the road ahead","volume":"367","author":"Murry","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2020.08.008_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nature13233","article-title":"Human embryonic-stem-cell-derived cardiomyocytes regenerate non-human primate hearts","volume":"510","author":"Chong","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib10","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1038\/nature19815","article-title":"Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts","volume":"538","author":"Shiba","year":"2016","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib11","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1038\/nbt.4162","article-title":"Human embryonic stem cell\u2013derived cardiomyocytes restore function in infarcted hearts of non-human primates","volume":"36","author":"Liu","year":"2018","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib12","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.stemcr.2019.04.005","article-title":"Human embryonic stem cell-derived cardiomyocytes regenerate the infarcted pig heart but induce ventricular tachyarrhythmias","volume":"12","author":"Romagnuolo","year":"2019","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib13","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/j.stemcr.2015.09.011","article-title":"Comparison of human embryonic stem cell-derived cardiomyocytes, cardiovascular progenitors, and bone marrow mononuclear cells for cardiac repair","volume":"5","author":"Fernandes","year":"2015","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib14","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1161\/CIRCRESAHA.117.310803","article-title":"Paracrine effects of the pluripotent stem cell-derived cardiac myocytes salvage the injured myocardium","volume":"121","author":"Tachibana","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.yjmcc.2010.08.005","article-title":"Paracrine mechanisms of stem cell reparative and regenerative actions in the heart","volume":"50","author":"Mirotsou","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib16","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1161\/CIRCRESAHA.108.176826","article-title":"Paracrine mechanisms in adult stem cell signaling and therapy","volume":"103","author":"Gnecchi","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib17","doi-asserted-by":"crossref","first-page":"2734","DOI":"10.1002\/stem.169","article-title":"Mesenchymal stem cells promote matrix metalloproteinase secretion by cardiac fibroblasts and reduce cardiac ventricular fibrosis after myocardial infarction","volume":"27","author":"Mias","year":"2009","journal-title":"Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib18","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1016\/j.yjmcc.2010.12.021","article-title":"Molecular and cellular mechanisms involved in cardiac remodeling after acute myocardial infarction","volume":"50","author":"Vilahur","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","article-title":"Regulation of the inflammatory response in cardiac repair","volume":"110","author":"Frangogiannis Nikolaos","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib20","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/CIRCRESAHA.117.310599","article-title":"Intravenously delivered mesenchymal stem cells","volume":"120","author":"Luger","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib21","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/s41586-019-1802-2","article-title":"An acute immune response underlies the benefit of cardiac stem cell therapy","volume":"577","author":"Vagnozzi","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib22","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1093\/cvr\/cvu167","article-title":"Extracellular vesicles from human cardiac progenitor cells inhibit cardiomyocyte apoptosis and improve cardiac function after myocardial infarction","volume":"103","author":"Barile","year":"2014","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib23","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.stemcr.2014.04.006","article-title":"Exosomes as critical agents of cardiac regeneration triggered by cell therapy","volume":"2","author":"Ibrahim Ahmed","year":"2014","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib24","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1159\/000438594","article-title":"Mesenchymal stem cell-derived exosomes improve the microenvironment of infarcted myocardium contributing to angiogenesis and anti-inflammation","volume":"37","author":"Teng","year":"2015","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.clinthera.2020.08.008_bib25","doi-asserted-by":"crossref","first-page":"e2277","DOI":"10.1038\/cddis.2016.181","article-title":"Cardiac progenitor cell-derived exosomes prevent cardiomyocytes apoptosis through exosomal miR-21 by targeting PDCD4","volume":"7","author":"Xiao","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/j.clinthera.2020.08.008_bib26","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat9683","article-title":"An off-the-shelf artificial cardiac patch improves cardiac repair after myocardial infarction in rats and pigs","volume":"12","author":"Huang","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib27","first-page":"201","article-title":"Exosomes secreted by cardiosphere-derived cells reduce scarring, attenuate adverse remodelling, and improve function in acute and chronic porcine myocardial infarction","volume":"38","author":"Gallet","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib28","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay2140","article-title":"Platelet-derived growth factor-AB improves scar mechanics and vascularity after myocardial infarction","volume":"12","author":"Thavapalachandran","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib29","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1089\/scd.2012.0542","article-title":"Progenitor cells identified by PDGFR-alpha expression in the developing and diseased human heart","volume":"22","author":"Chong","year":"2013","journal-title":"Stem Cell Devel"},{"key":"10.1016\/j.clinthera.2020.08.008_bib30","doi-asserted-by":"crossref","first-page":"2931","DOI":"10.1161\/CIRCULATIONAHA.118.035210","article-title":"Genetic Lineage tracing of Sca-1+ cells reveals endothelial but not myogenic contribution to the murine heart","volume":"138","author":"Vagnozzi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib31","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature13309","article-title":"c-kit+ cells minimally contribute cardiomyocytes to the heart","volume":"509","author":"van Berlo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib32","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1161\/CIRCULATIONAHA.118.036210","article-title":"Fate mapping of Sca1+ cardiac progenitor cells in the adult mouse heart","volume":"138","author":"Tang","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib33","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1001\/jamacardio.2016.2225","article-title":"Adult stem cell therapy and heart failure, 2000 to 2016: a systematic review","volume":"1","author":"Nguyen","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib34","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1161\/01.CIR.0000068356.38592.68","article-title":"Differentiation of human embryonic stem cells to cardiomyocytes: role of coculture with visceral endoderm-like cells","volume":"107","author":"Mummery","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib35","doi-asserted-by":"crossref","first-page":"E1848","DOI":"10.1073\/pnas.1200250109","article-title":"Robust cardiomyocyte differentiation from human pluripotent stem cells via temporal modulation of canonical Wnt signaling","volume":"109","author":"Lian","year":"2012","journal-title":"Proc Natl Acad Sci"},{"key":"10.1016\/j.clinthera.2020.08.008_bib36","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/nprot.2012.150","article-title":"Directed cardiomyocyte differentiation from human pluripotent stem cells by modulating Wnt\/\u03b2-catenin signaling under fully defined conditions","volume":"8","author":"Lian","year":"2013","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clinthera.2020.08.008_bib37","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.stem.2011.12.013","article-title":"Production of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming","volume":"10","author":"Burridge Paul","year":"2012","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib38","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1161\/CIRCRESAHA.108.192237","article-title":"Functional cardiomyocytes derived from human induced pluripotent stem cells","volume":"104","author":"Zhang","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib39","doi-asserted-by":"crossref","first-page":"394","DOI":"10.15252\/emmm.201404757","article-title":"Atrial-like cardiomyocytes from human pluripotent stem cells are a robust preclinical model for assessing atrial-selective pharmacology","volume":"7","author":"Devalla","year":"2015","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib40","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.99941","article-title":"Deep phenotyping of human induced pluripotent stem cell-derived atrial and ventricular cardiomyocytes","volume":"3","author":"Cyganek","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/j.clinthera.2020.08.008_bib41","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.stem.2019.02.015","article-title":"A\u00a0human iPSC double-reporter system enables purification of cardiac lineage subpopulations with distinct function and drug response profiles","volume":"24","author":"Zhang","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib42","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.yjmcc.2015.01.013","article-title":"Mechanism of automaticity in cardiomyocytes derived from human induced pluripotent stem cells","volume":"81","author":"Kim","year":"2015","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib43","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1161\/CIRCRESAHA.114.300558","article-title":"Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes","volume":"114","author":"Yang","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib44","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1253\/circj.CJ-19-0567","article-title":"Function follows form: a review of cardiac cell therapy","volume":"83","author":"Nakamura","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib45","first-page":"Cd007888","article-title":"Stem cell therapy for chronic ischaemic heart disease and congestive heart failure","volume":"12","author":"Fisher","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.clinthera.2020.08.008_bib46","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41569-018-0013-0","article-title":"Cell therapy trials for heart regeneration - lessons learned and future directions","volume":"15","author":"Menasch\u00e9","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib47","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S0008-6363(03)00254-2","article-title":"Myocyte and myogenic stem cell transplantation in the heart","volume":"58","author":"Dowell","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib48","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/S0140-6736(00)03617-5","article-title":"Myoblast transplantation for heart failure","volume":"357","author":"Menasch\u00e9","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib49","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1161\/CIRCULATIONAHA.107.734103","article-title":"The Myoblast Autologous Grafting in Ischemic Cardiomyopathy (MAGIC) trial: first randomized placebo-controlled study of myoblast transplantation","volume":"117","author":"Menasch\u00e9","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib50","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1093\/icvts\/ivt434","article-title":"Long-term follow-up after autologous skeletal myoblast transplantation in ischaemic heart disease","volume":"18","author":"Brickwedel","year":"2014","journal-title":"Interact Cardiovasc Thorac Surg"},{"key":"10.1016\/j.clinthera.2020.08.008_bib51","doi-asserted-by":"crossref","first-page":"805","DOI":"10.4244\/EIJV6I7A139","article-title":"Final results of a phase IIa, randomised, open-label trial to evaluate the percutaneous intramyocardial transplantation of autologous skeletal myoblasts in congestive heart failure patients: the SEISMIC trial","volume":"6","author":"Duckers","year":"2011","journal-title":"EuroIntervention"},{"key":"10.1016\/j.clinthera.2020.08.008_bib52","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1038\/nature06321","article-title":"Engraftment of connexin 43-expressing cells prevents post-infarct arrhythmia","volume":"450","author":"Roell","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib53","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.bbrc.2012.05.016","article-title":"Enhanced gap junction expression in myoblast-containing engineered tissue","volume":"422","author":"Srinivasan","year":"2012","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.clinthera.2020.08.008_bib54","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/35070587","article-title":"Bone marrow cells regenerate infarcted myocardium","volume":"410","author":"Orlic","year":"2001","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/nature02446","article-title":"Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts","volume":"428","author":"Murry","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib56","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/nature02460","article-title":"Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium","volume":"428","author":"Balsam","year":"2004","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib57","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.stem.2010.02.002","article-title":"Distinct hematopoietic stem cell subtypes are differentially regulated by TGF-beta1","volume":"6","author":"Challen","year":"2010","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib58","doi-asserted-by":"crossref","first-page":"I178","DOI":"10.1161\/CIRCULATIONAHA.104.522292","article-title":"Intracoronary injection of CD133-positive enriched bone marrow progenitor cells promotes cardiac recovery after recent myocardial infarction: feasibility and safety","volume":"112","author":"Bartunek","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib59","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1093\/eurheartj\/ehp073","volume":"30","author":"Tendera","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib60","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells: the International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.clinthera.2020.08.008_bib61","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nm.3028","article-title":"The meaning, the sense and the significance: translating the science of mesenchymal stem cells into medicine","volume":"19","author":"Bianco","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib62","doi-asserted-by":"crossref","first-page":"2884","DOI":"10.1634\/stemcells.2008-0329","article-title":"Bone marrow-derived mesenchymal stromal cells express cardiac-specific markers, retain the stromal phenotype, and do not become functional cardiomyocytes in\u00a0vitro","volume":"26","author":"Rose","year":"2008","journal-title":"Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib63","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1038\/nm1040","article-title":"Bone marrow\u2013derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation","volume":"10","author":"Nygren","year":"2004","journal-title":"Nat Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib64","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.1161\/01.CIR.0000034046.87607.1C","article-title":"Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans","volume":"106","author":"Strauer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib65","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00395-016-0592-z","article-title":"Identification of cardiovascular risk factors associated with bone marrow cell subsets in patients with STEMI: a biorepository evaluation from the CCTRN TIME and LateTIME clinical trials","volume":"112","author":"Contreras","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib66","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1161\/01.CIR.0000124476.32871.E3","article-title":"Profoundly reduced neovascularization capacity of bone marrow mononuclear cells derived from patients with chronic ischemic heart disease","volume":"109","author":"Heeschen","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib67","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.3727\/096368915X689901","article-title":"Identification of bone marrow cell subpopulations associated with improved functional outcomes in patients with chronic left ventricular dysfunction: an embedded cohort evaluation of the FOCUS-CCTRN trial","volume":"25","author":"Taylor","year":"2016","journal-title":"Cell Transpl"},{"key":"10.1016\/j.clinthera.2020.08.008_bib68","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/S0140-6736(04)16626-9","article-title":"Intracoronary autologous bone-marrow cell transfer after myocardial infarction: the BOOST randomised controlled clinical trial","volume":"364","author":"Wollert","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib69","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1056\/NEJMoa060186","article-title":"Intracoronary bone marrow-derived progenitor cells in acute myocardial infarction","volume":"355","author":"Sch\u00e4chinger","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib70","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1093\/eurheartj\/ehq455","article-title":"Intracoronary autologous mononucleated bone marrow cell infusion for acute myocardial infarction: results of the randomized multicenter BONAMI trial","volume":"32","author":"Roncalli","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib71","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.ijcard.2013.01.217","article-title":"A\u00a0pilot trial of autologous bone marrow mononuclear cell transplantation through grafting artery: a sub-study focused on segmental left ventricular function recovery and scar reduction","volume":"168","author":"Lu","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib72","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1016\/j.jacc.2011.01.037","volume":"57","author":"Hu","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib73","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1016\/j.athoracsur.2008.08.068","article-title":"Randomized study of mononuclear bone marrow cell transplantation in patients with coronary surgery","volume":"86","author":"Zhao","year":"2008","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.clinthera.2020.08.008_bib74","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s12265-009-9123-8","article-title":"Efficiency of intramyocardial injections of autologous bone marrow mononuclear cells in patients with ischemic heart failure: a randomized study","volume":"3","author":"Pokushalov","year":"2010","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib75","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1001\/jama.2013.3527","article-title":"Effect of shock wave-facilitated intracoronary cell therapy on LVEF in patients with chronic heart failure: the CELLWAVE randomized clinical trial","volume":"309","author":"Assmus","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.08.008_bib76","doi-asserted-by":"crossref","first-page":"2723","DOI":"10.1093\/eurheartj\/ehn436","article-title":"Effects of intracoronary injection of mononuclear bone marrow cells on left ventricular function, arrhythmia risk profile, and restenosis after thrombolytic therapy of acute myocardial infarction","volume":"29","author":"Huikuri","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib77","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ejhf.676","article-title":"An exploratory randomized control study of combination cytokine and adult autologous bone marrow progenitor cell administration in patients with ischaemic cardiomyopathy: the REGENERATE-IHD clinical trial","volume":"19","author":"Choudhury","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.clinthera.2020.08.008_bib78","first-page":"412","article-title":"LateTIME: a phase-II, randomized, double-blinded, placebo-controlled, pilot trial evaluating the safety and effect of administration of bone marrow mononuclear cells 2 to 3 weeks after acute myocardial infarction","volume":"37","author":"Traverse","year":"2010","journal-title":"Tex Heart Inst J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib79","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1001\/jama.2012.28726","article-title":"Effect of the use and timing of bone marrow mononuclear cell delivery on left ventricular function after acute myocardial infarction: the TIME randomized trial","volume":"308","author":"Traverse","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.08.008_bib80","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1161\/CIRCULATIONAHA.112.001035","article-title":"Intracoronary injection of bone marrow-derived mononuclear cells early or late after acute myocardial infarction: effects on global left ventricular function","volume":"127","author":"S\u00fcrder","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib81","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1001\/jama.2012.418","article-title":"Effect of transendocardial delivery of autologous bone marrow mononuclear cells on functional capacity, left ventricular function, and perfusion in chronic heart failure: the FOCUS-CCTRN trial","volume":"307","author":"Perin","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.08.008_bib82","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.healun.2014.02.009","article-title":"Autologous bone marrow mononuclear cell transplantation in ischemic heart failure: a prospective, controlled, randomized, double-blind study of cell transplantation combined with coronary bypass","volume":"33","author":"P\u00e4til\u00e4","year":"2014","journal-title":"J\u00a0Heart Lung Transpl"},{"key":"10.1016\/j.clinthera.2020.08.008_bib83","first-page":"437","article-title":"Direct intramyocardial transthoracic transplantation of bone marrow mononuclear cells for non-ischemic dilated cardiomyopathy: INTRACELL, a prospective randomized controlled trial","volume":"29","author":"Sant'Anna","year":"2014","journal-title":"Rev Bras Cir Cardiovasc"},{"key":"10.1016\/j.clinthera.2020.08.008_bib84","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1093\/eurheartj\/ehv477","article-title":"Multicentre, randomized, double-blind trial of intracoronary autologous mononuclear bone marrow cell injection in non-ischaemic dilated cardiomyopathy (the dilated cardiomyopathy arm of the MiHeart study)","volume":"36","author":"Martino","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib85","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/ncpcardio1321","article-title":"Randomized, controlled trial of intramuscular or intracoronary injection of autologous bone marrow cells into scarred myocardium during CABG versus CABG alone","volume":"5","author":"Ang","year":"2008","journal-title":"Nat Clin Pract Cardiovasc Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib86","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1056\/NEJMoa055706","article-title":"Intracoronary injection of mononuclear bone marrow cells in acute myocardial infarction","volume":"355","author":"Lunde","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib87","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/eurheartj\/ehq449","volume":"32","author":"Hirsch","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib88","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2013.282909","article-title":"Transendocardial mesenchymal stem cells and mononuclear bone marrow cells for ischemic cardiomyopathy: the TAC-HFT randomized trial","volume":"311","author":"Heldman","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.08.008_bib89","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1007\/s12265-014-9580-6","article-title":"Endomyocardial implantation of autologous bone marrow mononuclear cells in advanced ischemic heart failure: a randomized placebo-controlled trial (END-HF)","volume":"7","author":"Santoso","year":"2014","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib90","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1093\/eurheartj\/ehx188","article-title":"Intracoronary autologous bone marrow cell transfer after myocardial infarction: the BOOST-2 randomised placebo-controlled clinical trial","volume":"38","author":"Wollert","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib91","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.amjcard.2004.03.034","article-title":"Effect on left ventricular function of intracoronary transplantation of autologous bone marrow mesenchymal stem cell in patients with acute myocardial infarction","volume":"94","author":"Chen","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib92","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1161\/ATVBAHA.107.155317","article-title":"Cell-based therapy of myocardial infarction","volume":"28","author":"Dimmeler","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib93","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1161\/CIRCRESAHA.114.305495","article-title":"Allogeneic cell therapy: a new paradigm in therapeutics","volume":"116","author":"Karantalis","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib94","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1242\/jcs.02932","article-title":"Mesenchymal stem cells reside in virtually all post-natal organs and tissues","volume":"119","author":"Meirelles","year":"2006","journal-title":"J\u00a0Cell Sci"},{"key":"10.1016\/j.clinthera.2020.08.008_bib95","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.stem.2011.10.002","article-title":"Adult cardiac-resident MSC-like stem cells with a proepicardial origin","volume":"9","author":"Chong","year":"2011","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib96","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12916-015-0399-z","article-title":"Intracoronary infusion of Wharton's jelly-derived mesenchymal stem cells in acute myocardial infarction: double-blind, randomized controlled trial","volume":"13","author":"Gao","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib97","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jacc.2011.09.065","article-title":"First experience in humans using adipose tissue-derived regenerative cells in the treatment of patients with ST-segment elevation myocardial infarction","volume":"59","author":"Houtgraaf","year":"2012","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib98","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1093\/eurheartj\/ehv136","article-title":"Bone marrow-derived mesenchymal stromal cell treatment in patients with severe ischaemic heart failure: a randomized placebo-controlled trial (MSC-HF trial)","volume":"36","author":"Mathiasen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib99","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3346\/jkms.2014.29.1.23","article-title":"A\u00a0randomized, open-label, multicenter trial for the safety and efficacy of adult mesenchymal stem cells after acute myocardial infarction","volume":"29","author":"Lee","year":"2014","journal-title":"J\u00a0Korean Med Sci"},{"key":"10.1016\/j.clinthera.2020.08.008_bib100","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1001\/jama.2012.25321","article-title":"Comparison of allogeneic vs autologous bone marrow\u2013derived mesenchymal stem cells delivered by transendocardial injection in patients with ischemic cardiomyopathy: the POSEIDON randomized trial","volume":"308","author":"Hare","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/j.clinthera.2020.08.008_bib101","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jacc.2016.11.009","article-title":"Randomized comparison of allogeneic versus autologous mesenchymal stem cells for nonischemic dilated cardiomyopathy: POSEIDON-DCM Trial","volume":"69","author":"Hare","year":"2017","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib102","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/S0140-6736(16)30137-4","article-title":"Ixmyelocel-T for patients with ischaemic heart failure: a prospective randomised double-blind trial","volume":"387","author":"Patel","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib103","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1161\/CIRCRESAHA.115.306332","article-title":"A\u00a0Phase II dose-escalation study of allogeneic mesenchymal precursor cells in patients with ischemic or nonischemic heart failure","volume":"117","author":"Perin","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib104","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jcyt.2014.10.009","article-title":"Randomized, double-blind, phase I\/II study of intravenous allogeneic mesenchymal stromal cells in acute myocardial infarction","volume":"17","author":"Chullikana","year":"2015","journal-title":"Cytotherapy"},{"key":"10.1016\/j.clinthera.2020.08.008_bib105","first-page":"107","article-title":"[A prospective, randomized, controlled trial of autologous mesenchymal stem cells transplantation for dilated cardiomyopathy]","volume":"34","author":"Wang","year":"2006","journal-title":"Zhonghua Xin Xue Guan Bing Za Zhi"},{"key":"10.1016\/j.clinthera.2020.08.008_bib106","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s10529-014-1589-z","article-title":"The beneficial effects of intracoronary autologous bone marrow stem cell transfer as an adjunct to percutaneous coronary intervention in patients with acute myocardial infarction","volume":"36","author":"Wang","year":"2014","journal-title":"Biotechnol Lett"},{"key":"10.1016\/j.clinthera.2020.08.008_bib107","first-page":"648","article-title":"Cardiopoietic cell therapy for advanced ischaemic heart failure: results at 39 weeks of the prospective, randomized, double blind, sham-controlled CHART-1 clinical trial","volume":"38","author":"Bartunek","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib108","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1161\/CIRCRESAHA.117.311302","article-title":"Meta-analysis of cell therapy studies in heart failure and acute myocardial infarction","volume":"123","author":"Gy\u00f6ngy\u00f6si","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib109","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1093\/eurheartj\/ehx248","article-title":"Global position paper on cardiovascular regenerative medicine","volume":"38","author":"Fern\u00e1ndez-Avil\u00e9s","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib110","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S0092-8674(03)00687-1","article-title":"Adult cardiac stem cells are multipotent and support myocardial regeneration","volume":"114","author":"Beltrami","year":"2003","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib111","doi-asserted-by":"crossref","first-page":"14068","DOI":"10.1073\/pnas.0706760104","article-title":"Human cardiac stem cells","volume":"104","author":"Bearzi","year":"2007","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.clinthera.2020.08.008_bib112","doi-asserted-by":"crossref","first-page":"8701","DOI":"10.1038\/ncomms9701","article-title":"Resident c-kit+ cells in the heart are not cardiac stem cells","volume":"6","author":"Sultana","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2020.08.008_bib113","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.1038\/cddiscovery.2016.52","article-title":"Cardiac progenitor cells for heart repair","volume":"2","author":"Le","year":"2016","journal-title":"Cell Death Discov"},{"key":"10.1016\/j.clinthera.2020.08.008_bib114","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/S0140-6736(11)61590-0","article-title":"Cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"378","author":"Bolli","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib115","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(14)60608-5","article-title":"Expression of concern: the SCIPIO trial","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib116","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(19)30542-2","article-title":"Retraction: cardiac stem cells in patients with ischaemic cardiomyopathy (SCIPIO): initial results of a randomised phase 1 trial","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib117","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1161\/CIRCULATIONAHA.106.655209","article-title":"Regenerative potential of cardiosphere-derived cells expanded from percutaneous endomyocardial biopsy specimens","volume":"115","author":"Smith","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib118","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/01.RES.0000147315.71699.51","article-title":"Isolation and expansion of adult cardiac stem cells from human and murine heart","volume":"95","author":"Messina","year":"2004","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib119","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.yjmcc.2010.02.019","article-title":"Isolation and expansion of functionally-competent cardiac progenitor cells directly from heart biopsies","volume":"49","author":"Davis","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib120","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.jacc.2010.07.049","article-title":"Intramyocardial injection of autologous cardiospheres or cardiosphere-derived cells preserves function and minimizes adverse ventricular remodeling in pigs with heart failure post-myocardial infarction","volume":"57","author":"Lee","year":"2011","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib121","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(12)60195-0","article-title":"Intracoronary cardiosphere-derived cells for heart regeneration after myocardial infarction (CADUCEUS): a prospective, randomised phase 1 trial","volume":"379","author":"Makkar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib122","first-page":"1","article-title":"Intracoronary ALLogeneic heart STem cells to Achieve myocardial Regeneration (ALLSTAR): a randomized, placebo-controlled, double-blinded trial","author":"Makkar","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib123","doi-asserted-by":"crossref","first-page":"e866","DOI":"10.1212\/WNL.0000000000006950","article-title":"Cardiac and skeletal muscle effects in the randomized HOPE-Duchenne trial","volume":"92","author":"Taylor","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/j.clinthera.2020.08.008_bib124","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1161\/CIRCULATIONAHA.118.034250","article-title":"Genetic lineage tracing of nonmyocyte population by dual recombinases","volume":"138","author":"Li","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib125","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/j.clinthera.2020.08.008_bib126","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/nprot.2008.92","article-title":"Generation of human-induced pluripotent stem cells","volume":"3","author":"Park","year":"2008","journal-title":"Nat Protoc"},{"key":"10.1016\/j.clinthera.2020.08.008_bib127","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib128","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCRESAHA.110.227512","article-title":"Differentiation of human embryonic stem cells and induced pluripotent stem cells to cardiomyocytes: a methods overview","volume":"111","author":"Mummery","year":"2012","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib130","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1096\/fj.06-6769com","article-title":"Transplantation of undifferentiated murine embryonic stem cells in the heart: teratoma formation and immune response","volume":"21","author":"Nussbaum","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib131","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1161\/CIRCRESAHA.117.311578","article-title":"Lack of remuscularization following transplantation of human embryonic stem cell-derived cardiovascular progenitor cells in infarcted nonhuman primates","volume":"122","author":"Zhu","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib132","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/j.jacc.2017.11.047","article-title":"Transplantation of human embryonic stem cell-derived cardiovascular progenitors for severe ischemic left ventricular dysfunction","volume":"71","author":"Menasch\u00e9","year":"2018","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib133","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0002-9440(10)62041-X","article-title":"Formation of human myocardium in the rat heart from human embryonic stem cells","volume":"167","author":"Laflamme","year":"2005","journal-title":"Am J Pathol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib134","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.jacc.2007.07.054","article-title":"Transplantation of human embryonic stem cell-derived cardiomyocytes improves myocardial performance in infarcted rat hearts","volume":"50","author":"Caspi","year":"2007","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib135","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1161\/CIRCIMAGING.110.957431","article-title":"Long-term improvement in postinfarct left ventricular global and regional contractile function is mediated by embryonic stem cell-derived cardiomyocytes","volume":"4","author":"Qiao","year":"2011","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.clinthera.2020.08.008_bib136","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1038\/nature11317","article-title":"Human ES-cell-derived cardiomyocytes electrically couple and suppress arrhythmias in injured hearts","volume":"489","author":"Shiba","year":"2012","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib137","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/d41586-020-01285-w","article-title":"Revealed: two men in China were first to receive pioneering stem-cell treatment for heart disease","volume":"581","author":"Mallapaty","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib138","doi-asserted-by":"crossref","first-page":"6257","DOI":"10.1002\/jcp.29554","article-title":"Arrhythmogenic risks of stem cell replacement therapy for cardiovascular diseases","volume":"235","author":"Chen","year":"2020","journal-title":"J\u00a0Cell Physiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib139","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11936-008-0007-z","article-title":"Repairing damaged myocardium: evaluating cells used for cardiac regeneration","volume":"10","author":"Schuldt","year":"2008","journal-title":"Curr Treat Options Cardiovasc Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib140","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/nbt1014","article-title":"Electromechanical integration of cardiomyocytes derived from human embryonic stem cells","volume":"22","author":"Kehat","year":"2004","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib141","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/j.scr.2014.06.005","article-title":"Cardiac regeneration using pluripotent stem cells--progression to large animal models","volume":"13","author":"Chong","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib142","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1582-4934.2001.tb00170.x","article-title":"Gap junction remodeling and cardiac arrhythmogenesis: cause or coincidence?","volume":"5","author":"Severs","year":"2001","journal-title":"J\u00a0Cell Mol Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib143","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.hrthm.2009.07.043","article-title":"Phosphorylation of connexin43 on serine 306 regulates electrical coupling","volume":"6","author":"Procida","year":"2009","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.clinthera.2020.08.008_bib144","doi-asserted-by":"crossref","first-page":"2330","DOI":"10.1161\/CIRCULATIONAHA.108.789149","article-title":"Electrophysiological consequences of acute regional ischemia\/reperfusion in neonatal rat ventricular myocyte monolayers","volume":"118","author":"de Diego","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib145","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.cardiores.2003.07.004","article-title":"Conduction slowing by the gap junctional uncoupler carbenoxolone","volume":"60","author":"de Groot","year":"2003","journal-title":"Cardiovasc Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib146","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.yjmcc.2018.05.010","article-title":"Improving electrical properties of iPSC-cardiomyocytes by enhancing Cx43 expression","volume":"120","author":"Sottas","year":"2018","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib147","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1161\/01.CIR.100.2.193","article-title":"Survival, integration, and differentiation of cardiomyocyte grafts: a study in normal and injured rat hearts","volume":"100","author":"Reinecke","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib148","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1002\/stem.1331","article-title":"Concise review: maturation phases of human pluripotent stem cell-derived cardiomyocytes","volume":"31","author":"Robertson","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.clinthera.2020.08.008_bib149","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.stemcr.2016.10.009","article-title":"In\u00a0vivo maturation of human induced pluripotent stem cell-derived cardiomyocytes in neonatal and adult rat hearts","volume":"8","author":"Kadota","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib150","doi-asserted-by":"crossref","first-page":"19111","DOI":"10.1038\/srep19111","article-title":"Enhanced engraftment, proliferation and therapeutic potential in heart using optimized human iPSC-derived cardiomyocytes","volume":"6","author":"Funakoshi","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib151","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1089\/scd.2009.0052","article-title":"Absence of transverse tubules contributes to non-uniform Ca(2+) wavefronts in mouse and human embryonic stem cell-derived cardiomyocytes","volume":"18","author":"Lieu","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.clinthera.2020.08.008_bib152","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1089\/scd.2014.0533","article-title":"Immaturity of human stem-cell-derived cardiomyocytes in culture: fatal flaw or soluble problem?","volume":"24","author":"Veerman","year":"2015","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.clinthera.2020.08.008_bib153","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1038\/s41569-019-0331-x","article-title":"Cardiomyocyte maturation: advances in knowledge and implications for regenerative medicine","volume":"17","author":"Karbassi","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib154","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1634\/stemcells.2006-0466","article-title":"Developmental changes in cardiomyocytes differentiated from human embryonic stem cells: a molecular and electrophysiological approach","volume":"25","author":"Sartiani","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.clinthera.2020.08.008_bib155","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1089\/scd.2012.0490","article-title":"Structural and functional maturation of cardiomyocytes derived from human pluripotent stem cells","volume":"22","author":"Lundy","year":"2013","journal-title":"Stem Cell Dev"},{"key":"10.1016\/j.clinthera.2020.08.008_bib156","doi-asserted-by":"crossref","first-page":"10312","DOI":"10.1038\/ncomms10312","article-title":"Autonomous beating rate adaptation in human stem cell-derived cardiomyocytes","volume":"7","author":"Eng","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2020.08.008_bib157","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.stem.2018.09.009","article-title":"Single-cell transcriptomic analysis of cardiac differentiation from human pscs reveals HOPX-dependent cardiomyocyte maturation","volume":"23","author":"Friedman","year":"2018","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib158","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.stem.2017.07.003","article-title":"Human pluripotent stem cell-derived atrial and ventricular cardiomyocytes develop from distinct mesoderm populations","volume":"21","author":"Lee","year":"2017","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib159","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1253\/circj.CJ-12-0987","article-title":"Ultrastructural maturation of human-induced pluripotent stem cell-derived cardiomyocytes in a long-term culture","volume":"77","author":"Kamakura","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib160","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.scr.2013.09.003","article-title":"Myosin light chain 2-based selection of human iPSC-derived early ventricular cardiac myocytes","volume":"11","author":"Bizy","year":"2013","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib161","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.scr.2014.04.016","article-title":"SIRPA, VCAM1 and CD34 identify discrete lineages during early human cardiovascular development","volume":"13","author":"Skelton","year":"2014","journal-title":"Stem Cell Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib162","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nbt.3745","article-title":"Sinoatrial node cardiomyocytes derived from human pluripotent cells function as a biological pacemaker","volume":"35","author":"Protze","year":"2017","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib163","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.7150\/thno.19427","article-title":"Current strategies and challenges for purification of cardiomyocytes derived from human pluripotent stem cells","volume":"7","author":"Ban","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.clinthera.2020.08.008_bib164","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.stem.2012.09.013","article-title":"Distinct metabolic flow enables large-scale purification of mouse and human pluripotent stem cell-derived cardiomyocytes","volume":"12","author":"Tohyama","year":"2013","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib165","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/ten.tea.2016.0535","article-title":"Pivotal role of non-cardiomyocytes in electromechanical and therapeutic potential of induced pluripotent stem cell-derived engineered cardiac tissue","volume":"24","author":"Iseoka","year":"2018","journal-title":"Tissue Eng A"},{"key":"10.1016\/j.clinthera.2020.08.008_bib166","doi-asserted-by":"crossref","first-page":"6716","DOI":"10.1038\/srep06716","article-title":"Human iPS cell-engineered cardiac tissue sheets with cardiomyocytes and vascular cells for cardiac regeneration","volume":"4","author":"Masumoto","year":"2014","journal-title":"Sci Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib167","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s12265-010-9253-z","article-title":"Cell therapy for cardiovascular disease: a comparison of methods of delivery","volume":"4","author":"Dib","year":"2011","journal-title":"J\u00a0Cardiovasc Transl Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib168","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1016\/j.jacc.2009.04.097","article-title":"Noninvasive quantification and optimization of acute cell retention by in\u00a0vivo positron emission tomography after intramyocardial cardiac-derived stem cell delivery","volume":"54","author":"Terrovitis","year":"2009","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib169","doi-asserted-by":"crossref","first-page":"I150","DOI":"10.1161\/CIRCULATIONAHA.104.526749","article-title":"Radiolabeled cell distribution after intramyocardial, intracoronary, and interstitial retrograde coronary venous delivery: implications for current clinical trials","volume":"112","author":"Hou","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib170","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1016\/j.athoracsur.2011.07.012","article-title":"Stem cell engraftment and survival in the ischemic heart","volume":"92","author":"Wu","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.clinthera.2020.08.008_bib171","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jtcvs.2006.05.034","article-title":"Massive mechanical loss of microspheres with direct intramyocardial injection in the beating heart: implications for cellular cardiomyoplasty","volume":"132","author":"Teng","year":"2006","journal-title":"J\u00a0Thorac Cardiovasc Surg"},{"key":"10.1016\/j.clinthera.2020.08.008_bib172","first-page":"184","article-title":"Intramyocardial stem cell injection: go(ne) with the flow","volume":"38","author":"van den Akker","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.clinthera.2020.08.008_bib173","series-title":"Stem Cell Therapy and Tissue Engineering for Cardiovascular Repair: From Basic Research to Clinical Applications","author":"Dib","year":"2006"},{"key":"10.1016\/j.clinthera.2020.08.008_bib174","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.jcin.2009.12.013","article-title":"Recommendations for successful training on methods of delivery of biologics for cardiac regeneration: a report of the International Society for Cardiovascular Translational Research","volume":"3","author":"Dib","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/j.clinthera.2020.08.008_bib175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s12015-012-9367-6","article-title":"Comparison of cardiac stem cells and mesenchymal stem cells transplantation on the cardiac electrophysiology in rats with myocardial infarction","volume":"9","author":"Zheng","year":"2013","journal-title":"Stem Cell Rev Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib176","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1161\/CIRCULATIONAHA.106.659730","article-title":"Bioenergetic and functional consequences of bone marrow-derived multipotent progenitor cell transplantation in hearts with postinfarction left ventricular remodeling","volume":"115","author":"Zeng","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib177","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00395-017-0606-5","article-title":"Repeated doses of cardiac mesenchymal cells are therapeutically superior to a single dose in mice with old myocardial infarction","volume":"112","author":"Guo","year":"2017","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib178","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1038\/nbt1327","article-title":"Cardiomyocytes derived from human embryonic stem cells in pro-survival factors enhance function of infarcted rat hearts","volume":"25","author":"Laflamme","year":"2007","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib179","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/CIRCRESAHA.115.306985","article-title":"Human engineered heart muscles engraft and survive long term in a rodent myocardial infarction model","volume":"117","author":"Riegler","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/j.clinthera.2020.08.008_bib180","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.5966\/sctm.2015-0044","article-title":"Functional effects of a tissue-engineered cardiac patch from human induced pluripotent stem cell-derived cardiomyocytes in a rat infarct model","volume":"4","author":"Wendel","year":"2015","journal-title":"Stem Cell Transl Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib181","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1016\/j.stemcr.2017.09.003","article-title":"Human induced pluripotent stem cell-derived cardiomyocyte encapsulating bioactive hydrogels improve rat heart function post myocardial infarction","volume":"9","author":"Chow","year":"2017","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib182","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1038\/s41467-017-01946-x","article-title":"Cardiopatch platform enables maturation and scale-up of human pluripotent stem cell-derived engineered heart tissues","volume":"8","author":"Shadrin","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2020.08.008_bib183","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.omtm.2020.04.011","article-title":"Delta-1 functionalized hydrogel promotes hesc-cardiomyocyte graft proliferation and maintains heart function post-injury","volume":"17","author":"Gerbin","year":"2020","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.clinthera.2020.08.008_bib184","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.1016\/j.biomaterials.2013.04.026","article-title":"Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes","volume":"34","author":"Zhang","year":"2013","journal-title":"Biomaterials"},{"key":"10.1016\/j.clinthera.2020.08.008_bib185","doi-asserted-by":"crossref","first-page":"363ra148","DOI":"10.1126\/scitranslmed.aaf8781","article-title":"Cardiac repair in Guinea pigs with human engineered heart tissue from induced pluripotent stem cells","volume":"8","author":"Weinberger","year":"2016","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.clinthera.2020.08.008_bib186","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1016\/j.stem.2020.05.004","article-title":"Human-iPSC-derived cardiac stromal cells enhance maturation in 3D cardiac microtissues and reveal non-cardiomyocyte contributions to heart disease","volume":"26","author":"Giacomelli","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.clinthera.2020.08.008_bib187","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1161\/CIRCULATIONAHA.116.024145","article-title":"Defined engineered human myocardium with advanced maturation for applications in heart failure modeling and repair","volume":"135","author":"Tiburcy","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib188","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1161\/CIRCULATIONAHA.117.030785","article-title":"Large cardiac muscle patches engineered from human induced-pluripotent stem cell-derived cardiac cells improve recovery from myocardial infarction in swine","volume":"137","author":"Gao","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/j.clinthera.2020.08.008_bib189","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0131446","article-title":"Enhanced electrical integration of engineered human myocardium via intramyocardial versus epicardial delivery in infarcted rat hearts","volume":"10","author":"Gerbin","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.clinthera.2020.08.008_bib190","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1016\/j.jacc.2010.06.041","article-title":"Immunologic and inflammatory reactions to exogenous stem cells implications for experimental studies and clinical trials for myocardial repair","volume":"56","author":"Buja","year":"2010","journal-title":"J\u00a0Am Coll Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib191","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/bmb\/ldr018","article-title":"Cardiac cell therapy: where we've been, where we are, and where we should be headed","volume":"98","author":"Malliaras","year":"2011","journal-title":"Br Med Bull"},{"key":"10.1016\/j.clinthera.2020.08.008_bib192","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.stemcr.2016.01.012","article-title":"Cardiomyocytes derived from MHC-homozygous induced pluripotent stem cells exhibit reduced allogeneic immunogenicity in MHC-matched non-human primates","volume":"6","author":"Kawamura","year":"2016","journal-title":"Stem Cell Rep"},{"key":"10.1016\/j.clinthera.2020.08.008_bib193","doi-asserted-by":"crossref","first-page":"4357","DOI":"10.1038\/s41467-019-12324-0","article-title":"MHC matching fails to prevent long-term rejection of iPSC-derived neurons in non-human primates","volume":"10","author":"Aron Badin","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.clinthera.2020.08.008_bib194","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(05)67813-0","article-title":"Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching","volume":"366","author":"Taylor","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.clinthera.2020.08.008_bib195","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1634\/stemcells.2006-0566","article-title":"Human leukocyte antigen matching estimations in a hypothetical bank of human embryonic stem cell lines in the Japanese population for use in cell transplantation therapy","volume":"25","author":"Nakajima","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.clinthera.2020.08.008_bib196","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1038\/mt.2013.59","article-title":"HLA engineering of human pluripotent stem cells","volume":"21","author":"Riolobos","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.clinthera.2020.08.008_bib197","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.humimm.2017.10.017","article-title":"Regulatory dendritic cells for promotion of liver transplant operational tolerance: rationale for a clinical trial and accompanying mechanistic studies","volume":"79","author":"Thomson","year":"2018","journal-title":"Hum Immunol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib198","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.yjmcc.2010.09.008","article-title":"Human embryonic stem cell-derived cardiomyocytes engraft but do not alter cardiac remodeling after chronic infarction in rats","volume":"49","author":"Fernandes","year":"2010","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.clinthera.2020.08.008_bib199","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1177\/1074248413520344","article-title":"Electrical integration of human embryonic stem cell-derived cardiomyocytes in a Guinea pig chronic infarct model","volume":"19","author":"Shiba","year":"2014","journal-title":"J\u00a0Cardiovasc Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2020.08.008_bib200","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/nature10147","article-title":"Heart regeneration","volume":"473","author":"Laflamme","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.clinthera.2020.08.008_bib201","first-page":"1335","article-title":"Transforming the promise of pluripotent stem cell-derived cardiomyocytes to a therapy: challenges and solutions for clinical trials","volume":"30","author":"Prowse","year":"2014","journal-title":"Can J Cardiol"}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820303593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291820303593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T08:55:17Z","timestamp":1758963317000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291820303593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,10]]},"references-count":201,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S0149291820303593"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.08.008","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2020.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc.","name":"copyright","label":"Copyright"}]}}